Skip to main content
placeholder image

Results of crossover phase II component of randomized placebo-controlled trial evaluating oral THC/cannabis extract for refractory chemotherapy-induced nausea and vomiting (CINV).

Journal Article


Abstract


UOW Authors


  •   Aghmesheh, Morteza (external author)

Publication Date


  • 2020

Citation


  • Grimison, P. S., Stockler, M. R., Kirby, A., Walsh, A., Lintzeris, N., Cheung, Y., . . . Della-Fiorentina, S. (2020). Results of crossover phase II component of randomized placebo-controlled trial evaluating oral THC/cannabis extract for refractory chemotherapy-induced nausea and vomiting (CINV).. Journal of Clinical Oncology, 38(15_suppl), 12008. doi:10.1200/jco.2020.38.15_suppl.12008

Web Of Science Accession Number


Start Page


  • 12008

End Page


  • 12008

Volume


  • 38

Issue


  • 15_suppl

Place Of Publication


Abstract


UOW Authors


  •   Aghmesheh, Morteza (external author)

Publication Date


  • 2020

Citation


  • Grimison, P. S., Stockler, M. R., Kirby, A., Walsh, A., Lintzeris, N., Cheung, Y., . . . Della-Fiorentina, S. (2020). Results of crossover phase II component of randomized placebo-controlled trial evaluating oral THC/cannabis extract for refractory chemotherapy-induced nausea and vomiting (CINV).. Journal of Clinical Oncology, 38(15_suppl), 12008. doi:10.1200/jco.2020.38.15_suppl.12008

Web Of Science Accession Number


Start Page


  • 12008

End Page


  • 12008

Volume


  • 38

Issue


  • 15_suppl

Place Of Publication